Omeros Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® (narsoplimab-wuug) for the treatment of hematopoietic stem cell transplant-associated ...
Steadright Critical Minerals Inc. Board of Directors has approved an additional 1,200,000 options at 0.28 cents according to the Rolling Stock Option Plan approved by Shareholders at the Annual ...
Alta Copper Corp. is pleased to announce that the Supreme Court of issued an interim order dated 19, 2025 in connection with an arrangement involving Alta Copper, Fortescue Ltd. and Nascent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback